Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vito Annese

Showing results (61-70 of 182) with videos related to

Pageof 19
Sort By:
Annals of Gastroenterology|May 5, 2021
Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center studyMarco Le Grazie, Siro Bagnoli, Gabriele Dragoni, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 1, 2009
IL-1beta-511 and IL-1RN*2 polymorphisms in inflammatory bowel disease: An Italian population study and meta-analysis of European studiesVito D Corleto, Cristiano Pagnini, Giovanna Margagnoni, et al.
The American Journal of Gastroenterology|August 30, 2008
Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: a randomized, controlled studyFabrizio Bossa, Anna Latiano, Luigia Rossi, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|January 25, 2023
Composition of the gut microbiota in patients with inflammatory bowel disease in Saudi Arabia: A pilot studyHadba Al-Amrah, Omar I Saadah, Mahmoud Mosli, et al.
Frontiers in Oncology|February 14, 2025
Unraveling the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma: the "omics" eraAlberto Barchi, Giuseppe Dell'Anna, Luca Massimino, et al.
Bosnian Journal of Basic Medical Sciences|November 11, 2021
Attributes of intestinal microbiota composition and their correlation with clinical primary non-response to anti-TNF-α agents in inflammatory bowel disease patientsHanan Alatawi, Mahmoud Mosli, Omar I Saadah, et al.
Autoimmunity|April 5, 2014
Chronic inflammatory diseases: do immunological patterns drive the choice of biotechnology drugs? A critical reviewSilvano Sozzani, Maria P Abbracchio, Vito Annese, et al.
Journal of Proteome Research|August 29, 2023
Immunoglobulin A Glycosylation Differs between Crohn's Disease and Ulcerative ColitisFlorent Clerc, Karli R Reiding, Noortje de Haan, et al.
Journal of Crohn'S & Colitis|March 9, 2012
Neuroimmune interactions in patients with inflammatory bowel diseases: disease activity and clinical behavior based on Substance P serum levelsFrancesca Tavano, F Francesco di Mola, Anna Latiano, et al.
World Journal of Gastroenterology|December 3, 2020
First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensusMaryam Alkhatry, Ahmad Al-Rifai, Vito Annese, et al.
Pageof 19

Showing results (61-70 of 182) with videos related to

Sort By:
Pageof 19
Annals of Gastroenterology|May 5, 2021
Infliximab is more effective than cyclosporine as a rescue therapy for acute severe ulcerative colitis: a retrospective single-center studyMarco Le Grazie, Siro Bagnoli, Gabriele Dragoni, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 1, 2009
IL-1beta-511 and IL-1RN*2 polymorphisms in inflammatory bowel disease: An Italian population study and meta-analysis of European studiesVito D Corleto, Cristiano Pagnini, Giovanna Margagnoni, et al.
The American Journal of Gastroenterology|August 30, 2008
Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: a randomized, controlled studyFabrizio Bossa, Anna Latiano, Luigia Rossi, et al.
Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association|January 25, 2023
Composition of the gut microbiota in patients with inflammatory bowel disease in Saudi Arabia: A pilot studyHadba Al-Amrah, Omar I Saadah, Mahmoud Mosli, et al.
Frontiers in Oncology|February 14, 2025
Unraveling the pathogenesis of Barrett's esophagus and esophageal adenocarcinoma: the "omics" eraAlberto Barchi, Giuseppe Dell'Anna, Luca Massimino, et al.
Bosnian Journal of Basic Medical Sciences|November 11, 2021
Attributes of intestinal microbiota composition and their correlation with clinical primary non-response to anti-TNF-α agents in inflammatory bowel disease patientsHanan Alatawi, Mahmoud Mosli, Omar I Saadah, et al.
Autoimmunity|April 5, 2014
Chronic inflammatory diseases: do immunological patterns drive the choice of biotechnology drugs? A critical reviewSilvano Sozzani, Maria P Abbracchio, Vito Annese, et al.
Journal of Proteome Research|August 29, 2023
Immunoglobulin A Glycosylation Differs between Crohn's Disease and Ulcerative ColitisFlorent Clerc, Karli R Reiding, Noortje de Haan, et al.
Journal of Crohn'S & Colitis|March 9, 2012
Neuroimmune interactions in patients with inflammatory bowel diseases: disease activity and clinical behavior based on Substance P serum levelsFrancesca Tavano, F Francesco di Mola, Anna Latiano, et al.
World Journal of Gastroenterology|December 3, 2020
First United Arab Emirates consensus on diagnosis and management of inflammatory bowel diseases: A 2020 Delphi consensusMaryam Alkhatry, Ahmad Al-Rifai, Vito Annese, et al.
Pageof 19